Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
reports
4D Molecular Therapeutics (FDMT) Financial Statements
78 Followers
4D Molecular Therapeutics Financial Overview
| Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 298.00K | $ 1.25M | $ 500.00K | $ 162.00K | $ 1.22M |
| Gross Profit | $ 298.00K | $ 1.25M | - | - | - |
| EBIT | $ -30.13M | $ -28.72M | $ -26.50M | $ -28.43M | $ -26.39M |
| EBITDA | $ -29.11M | $ -27.56M | $ -25.62M | $ -27.59M | $ -25.61M |
| Net Income Common Stockholders | $ -28.68M | $ -27.38M | $ -25.69M | $ -28.09M | $ -26.34M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 200.45M | $ 213.55M | $ 227.72M | $ 241.09M | $ 236.15M |
| Total Assets | $ 244.02M | $ 261.85M | $ 280.16M | $ 302.94M | $ 324.93M |
| Total Debt | $ 15.68M | $ 16.12M | $ 16.55M | $ 17.00M | $ 16.82M |
| Net Debt | $ -184.77M | $ -197.43M | $ -211.16M | $ -224.09M | $ -219.33M |
| Total Liabilities | $ 25.41M | $ 30.51M | $ 28.72M | $ 30.42M | $ 28.87M |
| Stockholders Equity | $ 218.61M | $ 231.34M | $ 251.44M | $ 272.52M | $ 296.06M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -28.92M | $ -23.31M | $ -22.98M | $ -21.97M | $ -29.96M |
| Operating Cash Flow | $ -27.91M | $ -22.21M | $ -21.02M | $ -19.90M | $ -23.55M |
| Investing Cash Flow | $ 43.13M | $ -35.78M | $ 15.37M | $ 57.47M | $ -54.11M |
| Financing Cash Flow | $ 10.99M | $ 2.05M | $ 460.00K | $ -50.00K | $ 629.00K |